A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
Nov. 30, 2018
| By Sabin Russell / Fred Hutch News Service
In advance of World AIDS Day on Dec. 1, former Fred Hutch President and Director Dr. Larry Corey said he is "cautiously optimistic" about the current HIV vaccine trials. A renowned virologist, Corey has been a pioneer in HIV research since the beginning of the pandemic.
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Dec. 1, 2017
| By Mary Engel / Fred Hutch News Service
The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.